Related Experiment Videos
[Autoantibodies in hepatology]
C Johanet1, L Dubel, O Chazouillères
1Laboratoire d'Immunologie, Hôpital Saint-Antoine, Paris, France.
Pathologie-Biologie
|December 28, 1999
Summary
Diagnosing autoimmune liver diseases like primary biliary cirrhosis and autoimmune hepatitis relies on detecting specific serum autoantibodies. This review covers these antibodies, detection methods, identified antigens, and the role of Hepatitis C.
Area of Science:
- Hepatology
- Immunology
- Clinical Diagnostics
Context:
- Autoimmune liver diseases (ALD) encompass primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH), and primary sclerosing cholangitis (PSC).
- Accurate diagnosis of ALD is crucial for timely and effective treatment.
- Serum autoantibodies are key biomarkers in the diagnostic process for ALD.
Purpose:
- To review the spectrum of autoantibodies associated with primary biliary cirrhosis, autoimmune hepatitis, and primary sclerosing cholangitis.
- To discuss the methodologies employed for detecting these specific autoantibodies.
- To identify the known autoantigens targeted in autoimmune liver diseases.
Summary:
- Diagnostic criteria for autoimmune liver diseases involve the detection of specific autoantibodies in patient serum.
- This review details the various autoantibodies, their corresponding antigens, and the laboratory techniques used for their identification.
- The significant contribution of Hepatitis C virus infection to autoantibody production in liver disease is also examined.
Impact:
- Enhances understanding of serological markers for autoimmune liver disease diagnosis.
- Provides a consolidated resource for clinicians and researchers on autoantibodies in hepatology.
- Aids in differentiating autoimmune liver conditions from other liver pathologies, including viral hepatitis.